Your browser doesn't support javascript.
loading
Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML.
Zavorka Thomas, Megan E; Lu, Xiyuan; Talebi, Zahra; Jeon, Jae Yoon; Buelow, Daelynn R; Gibson, Alice A; Uddin, Muhammad Erfan; Brinton, Lindsey T; Nguyen, Julie; Collins, Meghan; Lodi, Alessia; Sweeney, Shannon R; Campbell, Moray J; Sweet, Douglas H; Sparreboom, Alex; Lapalombella, Rosa; Tiziani, Stefano; Baker, Sharyn D.
Affiliation
  • Zavorka Thomas ME; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Lu X; Department of Nutritional Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Talebi Z; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Jeon JY; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Buelow DR; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Gibson AA; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Uddin ME; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Brinton LT; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Nguyen J; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia.
  • Collins M; Department of Nutritional Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Lodi A; Department of Nutritional Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Sweeney SR; Department of Nutritional Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Campbell MJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Sweet DH; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia.
  • Sparreboom A; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Tiziani S; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Baker SD; Department of Nutritional Sciences and Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, Texas.
Mol Cancer Ther ; 20(11): 2207-2217, 2021 11.
Article in En | MEDLINE | ID: mdl-34518298
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Leukemia, Myeloid, Acute / Fms-Like Tyrosine Kinase 3 / Glutamine / Aniline Compounds Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Leukemia, Myeloid, Acute / Fms-Like Tyrosine Kinase 3 / Glutamine / Aniline Compounds Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article